Atlas Trials

A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)

Clinical trial NCT02509793 · UNKNOWN

Trial details

NCT number
NCT02509793
Sponsor
William Ondo, MD
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Huntington's Disease
Start date
2018-08-01
Primary completion
2023-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.